- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
Patent holdings for IPC class A61K 31/7008
Total number of patents in this class: 647
10-year publication summary
|
61
|
58
|
55
|
56
|
48
|
47
|
46
|
54
|
28
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amicus Therapeutics, Inc. | 354 |
17 |
| Société des Produits Nestlé S.A. | 9238 |
11 |
| The Regents of the University of California | 19493 |
11 |
| FLE International S.r.l. | 43 |
10 |
| Centre National de La Recherche Scientifique | 10068 |
7 |
| The Johns Hopkins University | 5524 |
7 |
| Nestec S.A. | 2709 |
6 |
| Farnam Companies, Inc. | 138 |
6 |
| Purepharm Inc. | 33 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2829 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3038 |
6 |
| Notogen, Inc. | 6 |
6 |
| Boehringer Ingelheim International GmbH | 4756 |
5 |
| Pfizer Inc. | 3371 |
5 |
| Marine Polymer Technologies, Inc. | 66 |
5 |
| The University of Tokyo | 4053 |
5 |
| U.S. Nutraceuticals, L.L.C., DBA Valensa International | 27 |
5 |
| Arrowhead Pharmaceuticals, Inc. | 294 |
4 |
| Australian Biomedical Company Pty Ltd. | 5 |
4 |
| Eaglepharma Pty Ltd | 4 |
4 |
| Other owners | 511 |